{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:40:42Z","timestamp":1785786042775,"version":"3.56.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/jcp.0b013e3182356255","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T08:09:11Z","timestamp":1319184551000},"page":"758-762","source":"Crossref","is-referenced-by-count":28,"title":["Aripiprazole and Dehydroaripiprazole Plasma Concentrations and Clinical Responses in Patients With Schizophrenia"],"prefix":"10.1097","volume":"31","author":[{"given":"Shih-Ku","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ken","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.","volume":"63","author":"Kane","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpsychires.2007.05.002","article-title":"A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg\/day for the treatment of patients with acute exacerbations of schizophrenia.","volume":"41","author":"McEvoy","year":"2007","journal-title":"J Psychiatr Res"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.","volume":"6","author":"Kasper","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/FTD.0b013e3181633429","article-title":"Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia.","volume":"30","author":"Bachmann","year":"2008","journal-title":"Ther Drug Monit"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2125.2008.03223.x","article-title":"Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.","volume":"66","author":"Kim","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/15622970701361255","article-title":"Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects.","volume":"9","author":"Kirschbaum","year":"2008","journal-title":"World J Biol Psychiatry"},{"issue":"suppl 1","key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1111\/j.1365-2125.2001.00174.x","article-title":"Therapeutic drug monitoring of psychotropic medications.","volume":"52","author":"Mitchell","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2004-832687","article-title":"The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.","volume":"37","author":"Baumann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.ftd.0000249944.42859.bf","article-title":"Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.","volume":"28","author":"Molden","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4088\/JCP.09r05060gre","article-title":"A systematic review of aripiprazole-dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring.","volume":"71","author":"Sparshatt","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia.","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11310820-000000000-00000","article-title":"Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.","volume":"23","author":"Mace","year":"2009","journal-title":"CNS Drugs"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/WNF.0b013e31817c6b06","article-title":"Efficacy and tolerability of aripiprazole in first-episode drug-naive patients with schizophrenia: an open-label trial.","volume":"32","author":"Takahashi","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.eurpsy.2007.03.002","article-title":"A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.","volume":"22","author":"Kerwin","year":"2007","journal-title":"Eur Psychiatry"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/FTD.0b013e3181b6326a","article-title":"Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia.","volume":"31","author":"Nakamura","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0091270004269870","article-title":"Pharmacokinetics of aripiprazole and concomitant lithium and valproate.","volume":"45","author":"Citrome","year":"2005","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201112000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T23:50:41Z","timestamp":1713052241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201112000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182356255","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}